Answer
Nebido (testosterone undecanoate) is contraindicated in men with androgen-dependent carcinoma of the prostate or male mammary gland, or past or present liver tumours.
Sources for this answer
- Nebido 1000 mg/4 ml, solution for injectionGrunenthal Ltd · emc · SmPC §4.3 Contraindications · Version 2Document updated
Sources checked